Zometa as a prophylactic treatment for bone mineral density loss in cancer patients following allogeneic stem cell transplantation,Australasian Leukaemia and Lymphoma Group,Interventional,Phase 2
This prospective study aimed to evaluate whether disease activity, disability, and glucocorticoid (GC) treatment in early RA were risk factors for loss of bone mineral density (BMD). We followed 97 women (mean age 58 years), for 24 months, with a history of RA of less than 12 months. ...
摘要：A method of treating an individual to increase the individual's bone mineral density (BMD) is disclosed. The method includes co-administering a calcitonin-like agent and a DHEA-like agent. Also disclosed are methods for potentiating the effect of treatment with a calcitonin-like agent on ...
Effects of treatment with fluoride on bone mineral density and fracture risk: a meta-analysis Vestergaard P, Jorgensen NR, Schwarz P, Mosekilde L (2008) Effects of treatment with fluoride on bone mineral density and fracture risk--a meta-... - Effects of treatment with fluoride on bone mine...
Although bone biopsy remains the gold standard for diagnosis, a variety of non-invasive measurements have also been developed. Among them is the determination of bone mineral density (BMD), which indicates how much mineralized bone is present. Another measurement, histomorphomethry, determines how ...
Effect of one year treatment of bone mineral density of celiac disease patients. Are calcium and vitamin D supplementation necessary?Effect of one year treatment of bone mineral density of celiac disease patients. Are calcium and vitamin D supplementation necessary?Ph.D. M. Jackson Marrdoi...
Effect of GH-treatment on bone mineral status in GHD-patients: Gender differencesdoi:10.1016/S1096-6374(98)80279-7T Rosén and BÅ Bengtsson and G JohannssonGrowth Hormone & IGF Research
Predictors for lumbar bone mineral density in premenopausal and postmenopausal women in Korea OBJECTIVE: The need for early and correct prescription for bone densitometry led to the research for decision model useful for clinicians to address women to bone densitometry. there are few studies that have...
Systemic delivery of NELL-1 to mice with gonadectomy-induced osteoporosis results in improved bone mineral density. When extended to a large animal model, local delivery of NELL-1 to osteoporotic sheep spine leads to significant increase in bone formation. Altogether, these findings suggest that ...
1 year of alendronate after 1 year of parathyroid hormone (1-84) treatment increased bone mineral density in osteoporosis: COMMENTARY. 1 year of alendronate after 1 year of parathyroid hormone (1-84) treatment increased bone mineral density in osteoporosisThis article comments on a study ... Jam...